PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: aLine Media - Public Relations

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Tenevis Receives Approval from The Food And Drug Administration to Be Used as An Orthosis Device - FDA-approved patented technology relieves back pain and improves foot health
Tenevis Receives Approval from The Food And Drug Administration to Be Used as An Orthosis Device

 

NewswireToday - /newswire/ - Los Angeles, CA, United States, 2011/03/03 - FDA-approved patented technology relieves back pain and improves foot health.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In an industry full of imitators, Tenevis is an innovator. Defined as “soft and powerful” in Latin, Tenevis walking and fitness shoes encourage better posture, improve foot health and relieve back pain with their patented technology.

Founded in Korea in 2007 by YS Hwang, Tenevis has received approval from the Food and Drug Administration to be used as an orthosis device. The Tenevis secret weapon is their patented balance bone and balance chip technologies. While other brands, like Skechers, use a rocker bottom to propel the foot forward, Tenevis focuses on providing a stable platform for the foot.

“We are not a rocker; we use very unique technology, ” said Tenevis President and COO David Corsi. “Rockers aren’t good for torsional stability. Tenevis is a powerful shoe that offers a soft ride while providing you with a very stable platform for walking.”

The balance bone is a steel shank that is integrated into the midsole and attached to a TPU plate. It extends from the heel to the midfoot and the TPU plate rests entirely under your foot. The system prevents your feet from swaying back and forth, while providing them with an accelerated energy, and maximizes muscle effort by allowing knees and ankles to move freely.

The balance chip absorbs shock in the heel, releasing tension as you walk and protecting knees, ankles and joints. This removable piece lasts as long as any polyurethane foam on the market today, and each pair of Tenevis shoes comes with two chips: a soft option and a firm one.

“Based on the surface you’re on, you can easily change the chip and decide what’s best for you, ” Corsi continued. “For example, you’d wear the softer chip on concrete, because it’ll provide a softer ride on the hard surface. If you’re walking on sand or on a trail, you’d use the firmer chip for more stability.”

In addition to being FDA-approved, the Tenevis technologies were tested at the Calgary Institute of Kinesiology in Canada to verify their health benefits. During the study, researchers rated the cushioning 127.5 percent higher than an average walking shoe. They also found that these heel-cushioning elements lower the impact of each step on contact, thus reducing stress on ankles, knees and hip joints by 30 to 40 percent. (The complete study is posted on Tenevis.com.)

The proven technology isn’t the only reason Tenevis is a leader in corrective and technical footwear. In addition to being stylish, the shoes were also designed especially for the female athletic walker.

“Women are looking for a walking-specific shoe, not a running shoe to walk in. But they don’t just want performance, they want something that looks appealing too, ” said Dan McCarthy, Tenevis designer and principal. “Our shoe provides more stability and better shock absorption than our competition, and our aesthetics make the shoes really easy to wear.”

Tenevis shoes are also slip-resistant and non-marking. They are great for people who are on their feet all day in their working environment. All-black and all-white leather styles cater to professionals in such industries as food service and health care.

The brand’s two styles, La Jolla and Cardiff, retail from $90 to $160. They are available in 40 retailers nationwide, Amazon.com and Tenevis.com. Tenevis will debut a men’s collection in April.

About Tenevis
Tenevis (tenevis.com), which is defined as “soft and powerful” in Latin, began as an idea by YS Hwang, the President of the Boss Corporation in Pusan, Korea. Hwang, an experienced footwear veteran, challenged his staff to create an innovative technology that could be used on many different design platforms.

With this challenge in hand, his staff created the patented balance bone and chip technologies. A study by The Calgary Institute of Kinesiology proves that these technologies increase the cushioning of the shoe by 127.5 percent, reduces the load on your joints by 30 to 40 percent and decreases muscle fatigue. In addition to this study, Tenevis has also received FDA approval as an orthosis corrective shoe.

Tenevis shoes are sold nationwide in specialty and orthopedic footwear stores. More information is available online.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: aLine Media - Public Relations

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Tenevis Receives Approval from The Food And Drug Administration to Be Used as An Orthosis Device

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Kenn Henman - aLineMedia.com 
213-624-0204 Kenn[.]alinemedia.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any aLine Media - Public Relations securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From aLine Media - Public Relations / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)